Post-transplant cyclophosphamide alters immune signatures and leads to impaired T cell reconstitution in allogeneic hematopoietic stem cell transplant

Despite the increased usage of post-transplant cyclophosphamide (PTCy) in allogeneic hematopoietic stem cell transplantation (allo-HSCT), our knowledge of immune reconstitution post-allo-HSCT in the setting of PTCy is limited. Adequate immune reconstitution is the key to a successful transplant. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Chenchen, Bartock, Matthew, Jia, Bei, Shah, Neal, Claxton, David F., Wirk, Baldeep, Rakszawski, Kevin L., Nickolich, Myles S., Naik, Seema G., Rybka, Witold B., Ehmann, W Christopher C., Hohl, Raymond J., Valentin, Jessica, Bernas-Peterson, Michelle, Gerber, Emily M., Zimmerman, Michele, Mierski, Joseph A., Mineishi, Shin, Zheng, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118756/
https://www.ncbi.nlm.nih.gov/pubmed/35590334
http://dx.doi.org/10.1186/s13045-022-01287-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118756/
https://www.ncbi.nlm.nih.gov/pubmed/35590334
http://dx.doi.org/10.1186/s13045-022-01287-3

Ejemplares similares